The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Adult vaccines continue to be one of the growing segment for pharmaceutical companies. The driving factors for adult vaccines growth are an increasing acceptance of adult vaccines and the public health focus on flu prevention, as well as introductions of new vaccines. The vaccines industry also faces hindrances such as vaccine safety, shortages and delays, vaccine development time line as well as entry barriers for new manufacturers.
Adult Vaccines Market - Disease Wise Analysis
The influenza vaccines capture maximum share of the total adult vaccines market. It is the most popular and accepted vaccination amongst adults. The hepatitis vaccines account for second highest share of the total adult vaccines market in 2015. The HPV/cervical cancer vaccines and pneumococcal vaccines captures the third and fourth highest share of the adult vaccines market respectively in 2015. While vaccines for zoster shingles and DTP are also gaining ground in adult vaccines market landscape.
Adult Vaccines Market - Company Analysis
Note: Novartis divested its non-influenza vaccine business to GlaxoSmithKline (GSK) and CSL acquired Novartis influenza vaccines business.
In 2010, GSK was the leader in the adult vaccines market but it lost the leadership position to Merck. Sanofi Pasteur stands at the second position in the adult vaccines market landscape. GSK slipped to third position in the global adult vaccines market in 2014. While Pfizer stands at the fourth spot in the adult vaccines market landscape.
Adult Vaccines Market - Disease Wise Company Sales Analysis
GSK generates maximum adult vaccines sales from Hepatitis and DTP vaccines, while Sanofi Pasteur remains focused on maintaining its leadership in the influenza vaccines market. The cervical cancer and zoster shingles vaccines contributes maximum share of the total Merck adult vaccines sales. Novartis main source of adult vaccines sales revenue is the influenza vaccines.
In 2011, Sanofi Pasteur replaced GSK and became the dominant player in the influenza vaccines landscape, while in the cervical cancer vaccines market, Merck is at the forefront and is expected to maintain its dominancy over a longer period of time. GSK is the clear leader in hepatitis vaccines market.
Adult Vaccines Market - Regional Distribution
On a regional basis, the United States comprises the single largest market for adult vaccines being closely followed by Europe. Japan’s adult vaccines market share is expected to remain flat during the forecasting period, while China’s adult vaccines market is likely to show continuous growth. South America and India are competing closely with each other to grab maximum share of the adult vaccines market pie.
This is the 2nd edition report on Adult Vaccines Market by iGATE RESEARCH. The report titled “Global - Adult Vaccines Market, Company Analysis and Forecast to 2021” is a 239 Page report with 141 Figures and 12 Tables. This report studies in detail the adult vaccines market disease wise, company wise sales analysis and strategic alliances, mergers and acquisitions along with growth drivers and hindrances for the vaccines market landscape.
The 9 Diseases covered in the report are analyzed from four viewpoints:
1. Adult Vaccines Market (2007 - 2021) 2. Number of Adults Vaccinated (2007 - 2021) 3. Number of Doses (2007 - 2021) 4. Company Sales Share (2010 - 2021)
The 7 Companies covered in the report are analyzed from two viewpoints:
Global Adult Vaccines Market - Company Analysis to 2021 (7 Companies Analysed)
1. GlaxoSmithKline 2. Sanofi Pasteur 3. Merck 4. Novartis 5. Pfizer 6. bioCSL (Seqirus) 7. Protein Sciences 8. Other Companies
Global Adult Vaccines Market - Regional Distribution to 2021 (8 Region Analysed)
1. United States 2. North America/Caribbean 3. South America 4. Europe 5. Japan 6. India 7. China 8. Rest of the World
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
272 pages •
By The Business Research Company
• Mar 2021
Antisense & RNAi Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global antisense & RNAi therapeutics market. Description: Where is the largest and fastest growing...
The Multiple Sclerosis Therapeutics market was valued at US$ 24,026.90 million in 2019 and it is projected to reach US$ 39,223.59 million by 2027; it is expected to grow at a CAGR of 6.5% from 2020 to 2027. The growth of the multiple sclerosis therapeutics market is mainly attributed to factors, such as growing prevalence of multiple...
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
257 pages •
By The Business Research Company
• Dec 2020
Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth provides the strategists, marketers and senior management with the critical information they need to assess the global anti-viral drug therapy market. Description: Where is the largest and fastest growing...
The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% during 2020–2027. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic...
Soluble Guanylate Cyclase - Pipeline Review, H2 2020
Soluble Guanylate Cyclase (sGC or EC 220.127.116.11) pipeline Target constitutes close to 29 molecules. Out of which approximately 26 molecules are developed by companies and remaining by the universities/institutes. The latest report Soluble...
The biofilms treatment market was valued at US$ 1,590.31 million in 2019 and is projected to reach US$ 2,825.80 million by 2027; it is expected to grow at a CAGR of 7.5% during 2020–2027. The increasing incidence of wounds and ulcers, and growing number of surgical procedures across the world fuel the market growth. Moreover, continuous innovations...
The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages,...
242 pages •
By The Business Research Company
• Dec 2020
CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T Therapy market. Description: Where is the largest and fastest growing market for the CAR-T therapy...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.